Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEEM R Lassen, W Fisher, P Mouret, et al.
The Journal of Laboratory and Clinical Medicine|August 12, 1999
Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjectsE A Braat, M Levi, R Bos, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2007
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory studyB I Eriksson, O E Dahl, M R Lassen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 1, 1992
Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation studyP Wille-Jørgensen, L Borris, L N Jørgensen, et al.
The Journal of Bone and Joint Surgery. British Volume|October 31, 2012
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programmeM R Lassen, M Gent, A K Kakkar, et al.
The Journal of Bone and Joint Surgery. British Volume|February 11, 2012
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trialsG E Raskob, A S Gallus, G F Pineo, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroupsG F Pineo, A S Gallus, G E Raskob, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2004
Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitisS Bloom, S Kiilerich, M R Lassen, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Pageof 7